NAME: Jianjun Xu
LAW FIRM: DeHeng Law Offices
PRACTICE AREAS: Capital markets, Corporate and M&A
Partner Jianjun Xu of DeHeng Law Offices wins our December lawyer of the month award for his role in Asymchem Laboratories’ $878 million secondary listing in Hong Kong. The transaction was Hong Kong’s biggest healthcare IPO in 2021. Xu and his team acted as the company’s PRC counsel throughout the deal.
Based in the firm’s Beijing office, Xu has over 20 years of experience in corporate finance, listings in domestic and overseas stock markets, and listed company M&As. He has an impressive track record serving as lead counsel for enterprises in financing projects and he focuses on a range of industry sectors such as banking and financial services, energy, pharmaceuticals, and TMT.
Pharmaceutical producer Asymchem Laboratories provides solutions throughout drug development and the manufacturing process. According to market research company Frost & Sullivan, the company is the fifth largest drug substance contract manufacturing organisation (CDMO) globally, and the largest China-based commercial stage chemical drug CDMO.